Incyte Corp. (INCY)
95.17
+0.01
(+0.01%)
USD |
NASDAQ |
Dec 10, 16:00
95.10
-0.06
(-0.07%)
After-Hours: 20:00
Incyte Market Cap: 18.68B for Dec. 10, 2025
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Eli Lilly & Co. | 889.33B |
| Halozyme Therapeutics, Inc. | 7.367B |
| Pfizer Inc. | 146.58B |
| Regeneron Pharmaceuticals, Inc. | 76.32B |
| Bio-Techne Corp. | 9.478B |
Market Cap Related Metrics
| PE Ratio | 15.97 |
| PS Ratio | 3.934 |
| PEG Ratio | 0.0039 |
| Price to Book Value | 4.017 |
| Price to Free Cash Flow | 16.15 |
| Price | 95.17 |
| Earnings Yield | 6.26% |
| PEGY Ratio | 0.0039 |
| Operating PE Ratio | 15.07 |
| Normalized PE Ratio | 18.44 |